CA

Camino Minerals Corporation

Advancing high-grade copper and precious metal projects from discovery to production.

COR | TSXV

Overview

Corporate Details

ISIN(s):
CA1380503070
LEI:
549300GNVV79CIRK4R32
Country:
Canada
Address:
666 Burrard Street, V6C 3P6 Vancouver
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Camino Minerals Corporation is a discovery-oriented mineral exploration and development company. It focuses on acquiring and advancing high-grade copper and precious metal projects, with a stated strategy of building a copper platform that spans from discovery to production. The company's portfolio includes key assets such as the Los Chapitos and Maria Cecilia exploration projects. Camino actively engages in exploration activities, including drilling, trenching, and sampling, to identify and define mineral resources for potential future development and mining operations.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-16 12:00
Regulatory News Service
Camino Announces High-Grade Copper at Los Chapitos
English 20.9 KB

Automate Your Workflow. Get a real-time feed of all Camino Minerals Corporation filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Camino Minerals Corporation

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Camino Minerals Corporation via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea
394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.